期刊文献+

阿尔茨海默病精神行为症状与血浆同型半胱氨酸水平关系的研究 被引量:5

Association between behavioral and psychological symptoms and plasma homocysteine level in patients with Alzheimer's disease
在线阅读 下载PDF
导出
摘要 目的探讨阿尔茨海默病(AD)精神行为症状(BPSD)与血浆同型半胱氨酸(HCY)水平的关系。方法对符合《精神障碍诊断和统计手册(第4版)》(DSM-Ⅳ)诊断标准的102例AD患者及80例对照组老年人进行血浆HCY测定,采用神经精神问卷(NPI)对AD患者进行测评,分为伴有BPSD组与不伴BPSD组,分析BPSD与血浆HCY水平的关系。结果 AD患者血浆HCY水平为(17.47±1.83)μmol/L,高于对照组(13.08±1.90)μmol/L,差异有统计学意义(t=14.663,P<0.001),伴BPSD组血浆HCY水平(17.48±1.85)μmol/L与不伴BPSD组(17.63±1.60)μmol/L比较,差异无统计学意义(t=0.299,P>0.05)。结论高同型半胱氨酸血症可能参与AD发病机制,而与BPSD的发生无关。 Objective To explore the association ketween Behavioral and Psychological Symptoms of Dementia( BPSD)of Alzhe=imerˊs disease(AD)and plasma homocysteine(HCY)level. Methods Plasma homocysteine levels were measured in 102 patients with AD and 80 healthy controls. BPSD of AD was assessed ky Neuropsychiatric Inventory( NPI),plasma HCY level was compared ketween BPSD group and non-BPSD group. Results Plasma HCY levels were significantly higher in AD group(17. 47 ± 1. 83)μmol/L than that in control group(13. 08 ± 1. 90)μmol/L(t=14. 663,P﹤0. 001). HCY levels had no difference ketween BPSD group (17. 46 ± 1. 85)μmol/L and non-BPSD group(17. 63 ± 1. 60)μmol/L(t=0. 299,P﹥0. 05). Conclusion Hyperhomocysteine may tade part in the pathogenesis of AD. HCY levels are not correlated to BPSD.
出处 《四川精神卫生》 2015年第3期203-205,共3页 Sichuan Mental Health
关键词 阿尔茨海默病 精神行为症状 同型半胱氨酸 Alzheimer 's disease Behavioral and psychological symptoms Homocystenine
作者简介 孙振晓,E-mail:szx.ywk@163.com
  • 相关文献

参考文献9

二级参考文献21

  • 1毕胜,王德生,张昱,吴江,盛雨辰,赵庆杰,潘尚哈.血管性痴呆患者与其血浆同型半胱氨酸水平的关系[J].中华老年心脑血管病杂志,2000,2(5):318-321. 被引量:17
  • 2Wang XL, Duarte N, Cai H, et al. Relationship between total plasma homocysteine, polymorphisms of homocysteine metabolism related enzymes, risk factors and coronary artery disease in the Australian hospital-based population[J]. Atherosclerosis,1999 Sep,14
  • 3Postiglione A, Milan G, Ruocco A, et al.Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia.A case-control study[J]. Geron
  • 4Nishiyama M, Kato Y, Hashimoto M, et al.Apolipoprotein E, methylenetetrahydrofolate reductase (MTHFR) mutation and the risk of senile dementia-an epidemiological study using the polymerase chain reaction (PCR) method[J]. J Epidemiol,2000 May,10(3):163-72.
  • 5Regland B, Blennow K, Germgard T, et al.The role of the polymorphic genes apolipoprotein E and methylene- tetrahydrofolate reductase in the development of dementia of the Alzheimer type[J]. Dement Geriatr Cogn Disord,1999 Jul-Aug,10(4):2452.
  • 6Tsai MY, Welge BG, Hanson NQ, et al. Genetic causes of mild hyperhomocysteinemia in patients with premature occlusive coronary artery diseases[J].Atherosclerosis,1999 Mar,143(1):163-70.
  • 7Whitehead A S, Gallagher P,Mills J L, et al,A genetic,defect in 5,10-methylenetetrahydrofolate reductase in neural tuve defects[J].Q J Med,1995,88:763-766.
  • 8Wakutani Y, Kowa H, Kusumi M,et al.Genetic analysis of vascular factors in Alzheimer's disease[J]. Ann N Y Acad Sci,2002,Nov,977:232-8.
  • 9Brunelli T, Bagnoli S, Giusti B, et al.The C677T methylenetetrahydrofolate reductase mutation is not associated with Alzheimer's disease[J]. Neurosci Lett,2001 Nov 23,315(1-2):103-5.
  • 10Pollak RD, Pollak A, Idelson M,et al.The C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and vascular dementia[J]. J Am Geriatr Soc,2000 Jun,48(6):664-8.

共引文献184

同被引文献28

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部